Caudal regression in adrenocortical dysplasia (acd) mice is caused by telomere dysfunction with subsequent p53-dependent apoptosis  by Vlangos, Christopher N. et al.
Developmental Biology 334 (2009) 418–428
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyCaudal regression in adrenocortical dysplasia (acd) mice is caused by telomere
dysfunction with subsequent p53-dependent apoptosis
Christopher N. Vlangos 1, Bridget C. O'Connor 1, Madeleine J. Morley, Andrea S. Krause,
Gail A. Osawa, Catherine E. Keegan ⁎
Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA
Department of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USA⁎ Corresponding author. 1150 W. Medical Center Dr.,
Arbor, Michigan 48109-5652, USA. Fax: +1 734 763 95
E-mail address: keeganc@med.umich.edu (C.E. Keeg
1 These authors contributed equally to this work.
0012-1606/$ – see front matter © 2009 Elsevier Inc. A
doi:10.1016/j.ydbio.2009.07.038a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 2 March 2009
Revised 22 July 2009
Accepted 29 July 2009
Available online 3 August 2009
Keywords:
Caudal regression
Telomere
Apoptosis
p53
Rescue
DevelopmentAdrenocortical dysplasia (acd) is a spontaneous autosomal recessive mouse mutation that exhibits a
pleiotropic phenotype with perinatal lethality. Mutant acd embryos have caudal truncation, vertebral
segmentation defects, hydronephrosis, and limb hypoplasia, resembling humans with Caudal Regression
syndrome. Acd encodes Tpp1, a component of the shelterin complex that maintains telomere integrity, and
consequently acd mutant mice have telomere dysfunction and genomic instability. While the association
between genomic instability and cancer is well documented, the association between genomic instability
and birth defects is unexplored. To determine the relationship between telomere dysfunction and embryonic
malformations, we investigated mechanisms leading to the caudal dysgenesis phenotype of acd mutant
embryos. We report that the caudal truncation is caused primarily by apoptosis, not altered cell proliferation.
We show that the apoptosis and consequent skeletal malformations in acd mutants are dependent upon the
p53 pathway by genetic rescue of the limb hypoplasia and vertebral anomalies with p53 null mice.
Furthermore, rescue of the acd phenotype by p53 deﬁciency is a dosage-sensitive process, as acd/acd,
p53−/− double mutants exhibit preaxial polydactyly. These ﬁndings demonstrate that caudal dysgenesis in
acd embryos is secondary to p53-dependent apoptosis. Importantly, this study reinforces a signiﬁcant link
between genomic instability and birth defects.
© 2009 Elsevier Inc. All rights reserved.Introduction
Adrenocortical dysplasia (Acdacd, hereafter denoted acd) is a
spontaneous autosomal recessive mouse mutation with defects in
adrenocortical development (Beamer et al., 1994). The acd mutation
was originally described in 1994 and is characterized by a postnatal
phenotype consisting of hypoplastic adrenal glands that contain
enlarged adrenocortical cellswith irregular nuclei, growth retardation,
skin hyperpigmentation, infertility due to lack of mature germ cells,
and hydronephrosis (Beamer et al., 1994; Keegan et al., 2005). On a
mixed genetic backgroundwith the CAST/Ei strain, approximately 10%
of mutants survive past birth although long term survival is reduced
(Keegan et al., 2005). On the DW/J strain, the acdmutant phenotype is
characterized by perinatal lethality, caudal truncation, vertebral
segmentation defects, and limb malformations (Keegan et al., 2005),
resembling Caudal Regression syndrome (CRS) in humans.3520C MSRB I, Box 5652, Ann
12.
an).
ll rights reserved.We previously reported that the acdmutant phenotype is due to a
splicing mutation in the Acd gene, which encodes the telomere
protein Tpp1 (Keegan et al., 2005). Tpp1 is a component of the
shelterin complex, which functions to protect the telomeres from
being recognized and processed by the DNA repair machinery and to
regulate telomerase access to telomeres (de Lange, 2005). Telomere
dysfunction is one mechanism that can give rise to genomic
instability, a classic characteristic of tumor cells, which can exhibit
aneuploidy due to structurally abnormal chromosomes or abnormal
chromosome numbers (Harrington and Robinson, 2002; Zhivotovsky
and Kroemer, 2004). RNAi knockdown of Acd expression in wildtype
mouse embryonic ﬁbroblast (MEF) cells causes telomere dysfunction,
leading to p53-mediated growth arrest and an ATM-dependent DNA
damage response (Guo et al., 2007). MEF cells from acd mutant
embryos are deﬁcient in Tpp1 protein at telomeres and exhibit
evidence of telomere dysfunction, including an increased number of
end-to-end chromosomal fusions, radial structures, and telomere
dysfunction-induced foci (Else et al., 2007; Hockemeyer et al., 2007).
However, acd mutant MEF cells do not exhibit a signiﬁcant change in
telomere length, suggesting that the observed telomere dysfunction is
due to uncapping and deprotection rather than telomere shortening
(Hockemeyer et al., 2007). The acd allele is hypomorphic based on the
419C.N. Vlangos et al. / Developmental Biology 334 (2009) 418–428presence of approximately 2% of appropriately spliced Acd mRNA in
homozygous acd MEF cells, and the worsening of telomere dysfunc-
tion in acd MEF cells following further RNAi knockdown of Acd
expression (Else et al., 2007; Hockemeyer et al., 2007).
The pleiotropic phenotype observed in acdmutant mice is unique.
Null mutations of the majority of shelterin proteins, with the
exception of Pot1b, exhibit early embryonic lethality (Celli and de
Lange, 2005; Chiang et al., 2004b; Hockemeyer et al., 2006; Karlseder
et al., 2003; Wu et al., 2006). While surviving acd mutant mice share
some phenotypic characteristics with Pot1b-null mice, including
growth retardation, hyperpigmentation, and germ cell depletion,
Pot1b-null mice are not known to exhibit embryonic malformations
(He et al., 2009; Hockemeyer et al., 2006; Hockemeyer et al., 2008).
Additional mutant mouse models exhibiting telomere dysfunction
include mice carrying null mutations in both the RNA component
(Terc) and catalytic reverse transcriptase (Tert) component of
telomerase (Blasco et al., 1997; Chiang et al., 2004a). However,
telomerase deﬁcient mice are viable and fertile for several generations
until their telomeres become critically short due to lack of telomerase
activity (Lee et al., 1998; Rudolph et al., 1999). An increase in the
number of neural tube defects has been reported in late generation
telomerase null embryos, but this phenotype more commonly affects
the rostral neural tube rather than the caudal region and is not fully
penetrant (Herrera et al., 1999).
Caudal Regression syndrome (CRS) is a heterogeneous condition in
humans affecting the caudal portion of the embryo that is thought to
be caused by both genetic and environmental factors (Bohring et al.,
1999). There is a signiﬁcant amount of overlap between CRS and other
caudal defects. In particular, CRS is thought to be part of a phenotypic
spectrum that includes VACTERL association (Kallen et al., 2001).
VACTERL is a non-random association of birth defects (vertebral
anomalies, anal atresia, cardiovascular anomalies, tracheo-esopha-
geal ﬁstula, renal anomalies, and preaxial limb anomalies) originally
described in 1973 (Quan and Smith, 1973). Both CRS and VACTERL are
usually sporadic and are thought to be genetically heterogeneous.
However, a small subset of patients with Fanconi anemia (FA) and
Rothmund–Thomson syndrome (RTS) exhibits a VACTERL phenotype
(Alter et al., 2007; Van Maldergem et al., 2006). While FA and RTS are
well known for their role in producing genomic instability and early
onset of cancer, the mechanisms by which genomic instability can
lead to congenital malformations in FA and RTS remain unexplored.
In this report, we have characterized the embryonic phenotype of
acdmutant mice in order to understand themechanism leading to the
caudal truncation phenotype. We hypothesized that the telomere
dysfunction caused by the acd mutation would lead to increased
apoptosis via p53 activation in acd mutant embryos. Further, we
hypothesized that characteristics of the acd phenotype might be
rescued when the acd mouse line was crossed to mice with a null
allele of Trp53 (hereafter denoted p53). Here, we show that acd
mutant embryos are present inMendelian ratios duringmid-gestation
when the caudal portion of the embryo is forming. The acd mutant
phenotype is evident by embryonic day (E) 9.5 as growth retardation,
while the characteristic caudal defects become progressively more
pronounced as development proceeds. This is accompanied by a
dramatic increase in cellular apoptosis but no signiﬁcant changes in
proliferation. Although acdmutant embryos exhibit caudal dysgenesis
characterized by vertebral and limb malformations, the process of
somitogenesis does not appear to be disrupted. We also demonstrate
that the skeletal anomalies and cellular apoptosis observed in acd
mutant embryos are rescued by p53 deﬁciency, although the perinatal
lethality of the acd mutation is not rescued. The acd mutant
phenotype provides a unique model system for studying the role of
telomere dysfunction in the manifestation of birth defects, and our
data reveal important insights into the potential mechanisms by
which telomere dysfunction and genomic instability can lead to
skeletal malformations.Materials and methods
Mice
We have maintained an acd breeding colony at the University of
Michigan since 2000 when DW/J heterozygous acd animals were
obtained from cryopreserved stock (stock# 001595) at the Jackson
Laboratories, Bar Harbor, ME, USA (Keegan et al., 2005). In order to
study strain speciﬁc phenotypes, heterozygous acd mice were back-
crossed to C57BL6/J mice. The data presented here represent embryos
from backcross generations N5–N10. p53 null mice (Jackson Labora-
tories, Bar Harbor, ME, USA; C57BL6/J; Trp53tm1Tyj stock #002103)
were obtained from a breeding stock maintained by the laboratory of
Dr. Gary Hammer at the University of Michigan. Mice were housed in
speciﬁc pathogen free and environmentally controlled conditions
with 14 hour light/10 hour dark cycles. Food andwater were provided
ad libitum. All experiments involvingmice have been approved by The
University of Michigan University Committee on Use and Care of
Animals.
Timed pregnancies
Matings for timed pregnancies were set up using standard animal
husbandry techniques. Noon of the day that a vaginal plug was
observed was considered E0.5. Embryos were genotyped using DNA
isolated from yolk sac as previously described (Keegan et al., 2005;
Truett et al., 2000). Chi-squared analysis was performed on litters
from the DW/J strain and the C57BL6/J backcross (N5–N7 generation)
to determine whether genotypes were present in expectedMendelian
ratios. In all experimental settings acd/acd, acd/+, and+/+ embryos
were examined. No phenotypic differences were observed between
acd/+ and +/+ embryos, consistent with previously published
data showing no difference in the cellular phenotype between +/+
and acd/+ MEF cells (Hockemeyer et al., 2007). For all experiments,
comparisons between acd mutant and wildtype embryos were made
on littermates.
Measurement of embryo size
Embryos were photographed under a Leica MZ10 dissecting
microscope, and the crown-to-rump length of the embryo was
measured on the printed photograph. For each litter, all acd mutant
embryos and at least one wildtype embryo were photographed and
measured. The percentage of size was calculated by dividing the
crown-to-rump length of each mutant by the crown-to-rump length
of the wildtype embryo (or average crown-to-rump length when
more than one wildtype embryo was photographed) multiplied by
100. Percentages were only calculated on embryos from within one
litter that were photographed at the same magniﬁcation. The number
of litters photographed per timepoint was 5 (E9.5), 9 (E10.5), and 12
(E11.5). Statistical signiﬁcance was determined using a two-tailed
paired student's t-test.
RNA whole mount in situ hybridization
Embryos were dissected in cold PBS, ﬁxed at 4 °C overnight in 4%
paraformaldehyde (PFA), rinsed in PBS, dehydrated through a graded
methanol series (25%, 50%, 75%, 100%) and stored at −20 °C in 100%
methanol until use. RNA whole mount in situ hybridization was
performed as previously described (Keegan et al., 2005). Digox-
igenin-labeled RNA antisense probes for Acd, Uncx4.1 (Mansouri
et al., 1997), Fgf8 (Sun et al., 2002), Brachyury (Wilson et al., 1993),
and Notch1 (Guillemot and Joyner, 1993) were prepared as
previously described (Keegan et al., 2005). The Acd cRNA probe for
whole mount in situ hybridization is 286 bp represented by GenBank
accession NM_001012638 bases 790 to 1076. The plasmid clone was
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GAAGGCTC; reverse primer: AGCTCTGGTCTCACAGGACTG) and
cloned into pGEM3Z using standard molecular biology techniques.
Immunoﬂuorescence on tissue sections
To detect cell proliferation, pregnant mice were injected intraper-
itoneally with BrdU at 100mg/g body weight for 1–2 h before embryo
removal. Embryos were ﬁxed for 1–2 h at room temperature in 4%
PFA, rinsed in PBS, dehydrated in an ethanol series, embedded in
parafﬁn, and sectioned at 7 μm thickness. For immunoﬂuorescence
studies sections were deparafﬁnized in xylene and rehydrated
through an ethanol series. Antigen retrieval was performed by boiling
tissue for 10min in 0.01M sodium citrate. Sectionswere blocked in 3%
bovine serum albumin in PBS and incubated at 4 °C overnight with
primary antibody. Sections were counterstained with propidium
iodide (PI) diluted at 1:1000–1:4000 or DAPI diluted at 1:1000
(Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA). For
BrdU, a polyclonal rat anti-BrdU antibody (Oxford Biotechnology,
Raleigh, NC, USA) was used at a 1:200 dilution, followed by
ﬂuorescent detection with a donkey anti-rat Alexa Fluor 488
secondary antibody diluted at 1:200 (Invitrogen, Carlsbad, CA, USA).
Rabbit polyclonal antibodies were used for Ki67 at 1:500 dilution
(Novocastra Laboratories, Newcastle Upon Tyne, UK) and cleaved
caspase-3 at 1:400 dilution (Cell Signaling Technology, Danvers, MA,
USA) with a biotinylated goat anti-rabbit secondary antibody (Vector
Labs, Burlingame, CA, USA) diluted at 1:200. Fluorescent detection
was performed using either Cy2- or Cy3-conjugated Streptavidin
diluted 1:600 (Jackson Immunoresearch, West Grove, PA, USA).
TUNEL analysis was performed using the ApopTag Red In Situ
Apoptosis Detection Kit as per the manufacturer instructions
(Chemicon International, Billerica, MA, USA) with a 10 minute
Proteinase K treatment.
Quantiﬁcation of immunoﬂuorescence and cell number
Cells were counted in transverse sections using a Leica DMRB
microscope 100× objective. Two 100× ﬁelds of vision were countedFig. 1. Acd is expressed ubiquitously during embryogenesis. Wildtype (A, B, D, E) and acdmut
Acd sense control probe (D, E).per section with 2 sections counted in total for each embryo. Three
wildtype embryos and three acd/acd embryos were counted for each
timepoint (E9.5, E10.5, and E11.5). Counterstained nuclei and primary
antibody-positive cells (Casp-3 or BrdU) were counted in the same
ﬁeld of vision to generate the fraction of positive cells in that ﬁeld of
vision. The number of DAPI- or PI-positive cells was used to determine
the total cell number (used in Fig. 2D). p-values were determined
using the two-tailed unpaired student's t-test.
p53×acd intercross and skeletal analysis
Heterozygous null p53 mice were crossed to acd heterozygous
mice (C57BL/6 background, N8–N10 generation). Resulting double
heterozygous mice (acd/+, p53+/−) were intercrossed to generate
double mutant mice (acd/acd, p53−/−). Genotype distributions at
weaning age (P21) and E15.5–E16.5 were analyzed by Chi-squared to
determine whether the genotypes were present in expected Mende-
lian ratios. Embryos were dissected at E15.5–E16.5 in fresh PBS and
immediately ﬁxed in 95% ethanol for 4 h. Skeletal staining with Alcian
Blue and Alizarin Red was performed as previously described
(Kimmel and Trammell, 1981). Stained skeletons were analyzed
under a Leica MZ7.5 dissecting microscope. The percentage of
abnormal/fused vertebrae per embryo was generated by dividing
the average number of abnormal/fused vertebrae per embryo by the
total number of vertebrae per embryo. An unpaired student's t-test
was performed to determine statistical signiﬁcance.
Results
The Acd gene is widely expressed in the embryo with relatively higher
levels in the limb buds and tail
Little is known about the expression of Acd, other than the
detection of transcripts in multiple adult tissues and throughout
development by northern analysis and RT-PCR (Keegan et al., 2005).
The ﬁnding that Acd encodes a telomeric protein supports the
possibility that the gene is expressed ubiquitously. However, because
the acd embryonic phenotype manifests in the caudal portion of theant (C) embryos hybridized with digoxigenin labeled Acd antisense RNA probe (A–C) or
Table 1
Genotypes reveal viability of acdmutant embryos on DW/J and C57BL/6 strains at E9.5
to E 11.5.
Embryonic
timepoint
Total number
of embryos
+/+ acd/+ acd/acd p valuea
E9.5 59 11 30 18 0.5NpN0.3
E10.5 61 11 35 15 0.5NpN0.3
E11.5 65 15 36 14 0.8NpN0.7
Total 185 37 101 47 0.3NpN0.2
Strain
DW/J 102 20 60 22 0.2NpN0.1
B6 83 17 41 25 0.5NpN0.3
Total 185 37 101 47 0.3NpN0.2
a For predicted Mendelian ratios, df=2.
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throughout the embryo. To test this hypothesis, we performed whole
mount in situ hybridization on wildtype embryos using an Acd cRNA
probe (Fig. 1). At E9.5, we observed widespread expression of the Acd
gene uniformly throughout the embryo (Fig. 1A). At E11.5, however,
we observed a relatively higher concentration of Acd mRNA in the
neural tube, limb buds, tail, and developing craniofacial region (Fig.
1B). A similar pattern of expression was observed in acd mutant
embryos at E11.5, although with slightly reduced staining intensity
(Fig. 1C). This result was expected as our group has previously shown
the presence of Acd mRNA in mutant embryos by RT-PCR and
northern blot analysis (Keegan et al., 2005). The expression pattern
we observed at E11.5 resembles the expression pattern of Tert at E11
(Martin-Rivera et al., 1998).
acd mutant embryos are growth retarded and exhibit reduced cellularity
The acdmutation exhibits perinatal lethality and caudal truncation
on the DW/J strain (Keegan et al., 2005). Affected F2 animals from a
DW/J×C57BL6/J intercross had a similar embryonic phenotype
(Keegan et al., 2005). To date we have backcrossed the acd mutation
onto the C57BL6/J (B6) strain for 10 generations. Data were collected
from DW/J embryos and B6 backcross embryos from generations N5–
N7, which yields a hypothetical puriﬁcation of 97–99% B6 DNA. On
both the DW/J and B6 strains, we observed Mendelian ratios of
mutant embryos from E9.5 to E11.5, during the period of formation of
the caudal region (Table 1). Overall, the embryonic phenotype on the
B6 strain was similar to the DW/J embryonic phenotype (Keegan
et al., 2005). Compared to wildtype littermates, acd mutant embryos
were growth retarded, although there was some variability in the size
of mutant embryos within a litter (Figs. 2A, B). In addition, the caudal
truncation phenotype was less pronounced at these early timepoints.
Measurement of the crown-to-rump length demonstrated that acd
mutants were 71.6% (±3.8%) the size of wildtype littermate embryos
at E9.5, 77.4% (±1.8%) at E10.5, and 79.1% (±1.4%) at E11.5 (Fig. 2C).
The growth retardation phenotype of acdmutant embryos suggests a
net reduction in cells. To conﬁrm this, we counted the number of cells
per high power ﬁeld in acd embryos versus wildtype littermates, and
we found that acd mutant embryos do indeed have fewer cells per
high power ﬁeld at E9.5 through E11.5 (Figs. 2C, D, F). Occasional
changes in cellular morphology were noted in acd mutant embryo
sections, including irregularly shaped nuclei, pyknotic nuclei, and
nuclear fragments (data not shown). As expected, occasional
anaphase bridges were also observed in acd mutant tissue sections
(data not shown) (Else et al., 2007).
At E8.5, Mendelian genotype ratios were observed. In addition, at
E8.5 most acdmutant embryos were indistinguishable from wildtype
embryos, and the number of somites was in the normal range. In a few
litters we observedmild growth retardation in acdmutant embryos at
E8.5 (data not shown).acd mutant embryos exhibit widespread apoptosis but no signiﬁcant
differences in cell proliferation
Acd encodes a telomere protein, and cells from acd mice exhibit
telomere dysfunction, which is known to lead to cell cycle arrest or
apoptosis via activation of p53. To detect changes in the number of
apoptotic cells, we performed TUNEL staining and immunoﬂuores-
cence with an antibody to cleaved caspase-3 (Casp-3), a marker of
the apoptosis pathway. At E9.5–E11.5, we observed an increase in
cells undergoing apoptosis by TUNEL staining and Casp-3 immuno-
ﬂuorescence in mutant embryos compared to wildtype controls (Figs.
3B, D, G, I). Immunoﬂuorescence for the proliferation markers Ki67 or
BrdU did not reveal a difference in the number of proliferating cells
(Figs. 3E, J). To quantify these observations, we counted Casp-3
positive and BrdU-positive cells from E9.5 through E11.5. This
analysis revealed a signiﬁcant increase in the fraction of Casp-3
positive cells at all timepoints (0.1 vs. 0.02 at E9.5, 0.29 vs. 0.03 at
E10.5, 0.22 vs. 0.02 at E11.5, Fig. 3K). There was no difference in the
fraction of BrdU-positive cells at E9.5–E11.5 (Fig. 3L). These studies
support the hypothesis that apoptosis is the major mechanism
leading to reduction of the caudal region of acd mutant embryos.
Despite the fact that the mutant phenotype appears to be more
pronounced in the caudal region of the embryo at E14–16 (Keegan
et al., 2005), increased apoptosis was not limited to the caudal region
but was widespread throughout the embryo (data not shown). This
supports the observed global growth retardation of acd mutant
embryos (Fig. 2).
acd mutant embryos exhibit normal somite segmentation and patterning
of the caudal region
The presence of vertebral segmentation anomalies in acd mutant
embryos at E16 suggested the possibility that the process of
somitogenesis is disrupted by the acd mutation (Keegan et al.,
2005). To test this hypothesis, we performed whole mount in situ
hybridization with several markers of somitogenesis and tail bud
development on acdmutant and wildtype littermate embryos at E9.5.
To investigate the overall patterning of somites, we examined the
expression of Uncx4.1, which is expressed in the posterior half of each
somite (Leitges et al., 2000; Mansouri et al., 2000). At E9.5 we
observed normal patterning of Uncx4.1 expression in the somites of
mutant embryos (Figs. 4A, B). Cyclic activation of the Notch signaling
pathway is thought to be the signal for somite formation from the
presomitic mesoderm (PSM) (Jouve et al., 2000). Notch1 is expressed
at the boundary of somite formation, followed caudally by a gradient
within the PSM (Aulehla et al., 2003). In acdmutant embryos at E9.5,
we observed a normal pattern of Notch1 expression at the somite
boundary and PSM, but reduced intensity of expression (Figs. 4C, D).
Fgf8 is expressed in a caudal-to-rostral gradient within the PSM at
E9.5 and is thought to represent the somite boundary determination
front (Dubrulle et al., 2001). In acd mutant embryos, we observed a
normal pattern of Fgf8 expression that included a gradient within the
PSM with reduced expression (Figs. 4E, F). Brachyury (T), the
prototypical T-box gene is ﬁrst expressed in tailbud and notochord
and is thought to be a direct target ofWnt3a in the tailbud (Yamaguchi
et al., 1999). We observed a normal pattern of T expression in acd
mutant embryos compared to wildtype littermates (Figs. 4G, H).
Taken together, these data indicate that disrupted somitogenesis is
not the cause of the caudal dysgenesis phenotype in acd mutant
embryos.
p53 deﬁciency does not rescue the embryonic lethality of acd mutant
embryos
To determine whether p53-dependent apoptosis is responsible for
the embryonic phenotypes of acd mutant embryos, we crossed
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the progeny of double heterozygote (acd/+, p53+/−) intercrosses.
We did not detect surviving acd mutant mice at weaning age (P21),
regardless of p53 genotype (Table 2). A small deﬁciency of p53−/−
mice was observed (Table 2), as expected based on previouslyFig. 2. acd mutant embryos are growth retarded and exhibit reduced cellularity. Compari
retardation of mutant embryos. H & E photograph of acdmutant (C) and wildtype (D) tissue
magniﬁcation of the boxed area representing a typical area in which cell numbers were coun
Calculation of percent size of wildtype littermates demonstrates statistically signiﬁcant redu
t-test. (F) Quantiﬁcation of number of cells per high power ﬁeld reveals a statistically sign
pb0.05 by student's t-test.published studies of p53 null mice (Sah et al., 1995). p53 deﬁciency
thus does not rescue the known embryonic lethality of the acd
mutation on the C57BL/6J strain. Mendelian genotype ratios were
observed at E15.5–E16.5 (Table 3), suggesting that the observed
lethality is perinatal.son of acd mutant and wildtype littermates at (A) E9.5 and (B) E10.5 shows growth
sections shows reduced cellularity in acdmutant mesenchyme. Insets depict high power
ted. Scale bars represent 100 μm in low power ﬁgure and 20 μm in high power inset. (E)
ction in size of acdmutant embryos at all timepoints. ⁎Represents pb0.001 by student's
iﬁcant decrease in cell number in acd mutant embryos at E9.5 and E11.5. ⁎Represents
Fig. 3. acdmutant embryos exhibit increased apoptosis. Transverse sections of wildtype (A–E) and mutant (F–J) acd embryos at E11.5. TUNEL staining (B, G) and cleaved caspase-3
immunohistochemistry (D, I) show an increase in the number of apoptotic cells in acd mutant embryos (G, I). A and F show DAPI counterstain of section in panel B and G,
respectively, and C and H show propidium iodide (PI) counterstain of section in panel D and I, respectively. (E, J) Immunohistochemistry for Ki67 (green) with propidium iodide
(red) counterstain shows no signiﬁcant difference in the number of proliferating cells in WT (E) vs. acd mutant (J) embryos. (K) Average fraction of caspase-3 positive cells in
wildtype (black) and acd mutant (white) embryos is signiﬁcantly different at all timepoints. ⁎Denotes pb0.001 by student's t-test. (L) Average fraction of BrdU-positive cells in
wildtype (black) and acd mutant (white) embryos shows no statistically signiﬁcant differences.
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Analysis of E15.5–E16.5 skeletons stained with Alcian Blue and
Alizarin Red revealed that the majority of acd/acd, p53+/+ embryos
exhibited hypoplasia of the medial digits in at least one hindlimb,
occasionally accompanied by an absent tibia, consistent with our
previous results (Keegan et al., 2005) (Fig. 5A, Table 4). The majority
of acd/acd, p53+/− embryos had normal hindlimbs, although some
embryos exhibited digit hypoplasia, missing digits, or biﬁd digits
(Fig. 5B, Table 4). No hindlimb abnormalities were observed in acd/+,
p53−/− or +/+, p53−/− embryos (Table 4). In double mutant
(acd/acd, p53−/−) embryos we observed preaxial (medial) polydac-
tyly or biﬁd ﬁrst digits of at least one hindlimb in all embryos (Fig. 5C,
Table 4). The majority of embryos had normal forelimbs; however,
we did observe absent or hypoplastic digits in a few embryos
(Supplementary Table 1). All other embryos had normal limbs
(Fig. 5D, Table 4). This suggests that p53-dependent apoptosis in
the limb bud is responsible for the limb hypoplasia observed in acd
mutant embryos. In the absence of p53, there is excess proliferation
giving rise to an extra digit.
Vertebral fusions mostly notable in the lumbar region were
previously observed in acd mutant embryos (Keegan et al., 2005).
To our knowledge, vertebral fusions have not been reported
previously in p53-deﬁcient mice. We examined the number and
morphology of vertebrae by skeletal staining in embryos from double
heterozygote intercrosses (Figs. 5E, F, G, H, Supplementary Table 2). In
wildtype embryos minor vertebral anomalies were observed in ≤5%
of vertebrae suggesting a low level of normal background variation
(Figs. 5H, I, Supplementary Table 2). There were multiple vertebral
fusion anomalies noted in acd/acd, p53+/+ embryos (Figs. 5E, I).
There was some improvement in acd/acd, p53+/− embryos, althoughthey still displayed a signiﬁcant number of vertebral anomalies
(Figs. 5F, I). However, double mutant embryos lacked vertebral
fusions and displayed only minor variations similar to background
levels, demonstrating complete rescue of this aspect of the acdmutant
phenotype (Figs. 5G, I, Supplementary Table 2). We also observed a
signiﬁcant number of abnormal vertebrae in acd/+, p53−/− embryos,
but only occasional abnormalities in acd/+, p53+/− and +/+,
p53−/− embryos (similar to wildtype embryos), suggesting that gene
dosage of either Acd or p53 is important for this effect (Supplementary
Table 2). These data demonstrate that a p53-dependent process is
responsible for the vertebral fusions in acd mutant mice.
Several additional anomalies were more common in embryos with
either acd mutant or p53 null genotypes, including unilateral ocular
aplasia, mandibular hypoplasia, and exencephaly (Supplementary
Table 3). Mutant acd embryos exhibited growth retardation regardless
of p53 genotype, although retardation was less severe in p53+/− and
p53−/− embryos compared to p53+/+ embryos (data not shown).
p53 deﬁciency results in rescue of cellular apoptosis
To conﬁrm that the apoptosis we observed in younger embryos
was due to the activation of p53, we performed immunoﬂuorescence
for Casp-3 on tissue sections from acd mutant and double mutant
embryos from the acd×p53 cross. We observed a signiﬁcant increase
in Casp-3 immunoﬂuorescence in acd/acd, p53+/+ embryos at E10.5,
similar to our previous observations in acd mutant embryos (Figs.
6D–F). However, in acd/acd, p53−/− embryos, we observed back-
ground levels of Casp-3 immunoﬂuorescence (Figs. 6G–I), similar to
levels observed in wildtype embryos (Figs. 6A–C). These ﬁndings
conﬁrm that the cellular apoptosis in acd mutant embryos is p53-
dependent.
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In this report, our characterization of the acd mutant embryonic
phenotype has allowed us to gain new mechanistic insight into the
cause of the caudal truncation phenotype. This work clearly reinforces
the link between speciﬁc birth defects that parallel human malfor-
mation syndromes and genomic instability that results from telomere
dysfunction, an area that has not previously been studied carefully.
We observed a ubiquitous pattern of Acd expression in wildtype
embryos at E9.5, consistent with the known function of Tpp1 as an
integral component of the shelterin telomere complex. We did not
examine earlier timepoints by whole mount in situ hybridization,
though we previously demonstrated the expression of Acd mRNA atFig. 4. Somitogenesis and tail bud markers show normal expression patterning in acd muta
at E9.5 using the somite marker Uncx4.1 (A, B), the presomitic mesoderm marker Notch1
boundary is denoted by arrow in (C) and (D). In general, the expression patterns are norE7.5 and in ES cells by RT-PCR (Keegan et al., 2005). At E11.5
expression was increased in the limb buds, tail tip, neural tube, and
the craniofacial region relative to other tissues. The regions with
higher expression correspond to the regions that are most affected in
acd mutant embryos, and resemble the expression pattern of the
enzymatic component of telomerase (Tert) during development
(Martin-Rivera et al., 1998). This suggests that there are populations
of rapidly proliferating cells in these regions with a higher
requirement for telomerase and telomere proteins.
We found that acd mutant embryos are present in Mendelian
ratios during mid-gestation when the caudal portion of the embryo is
forming. The acdmutant phenotype is visible by embryonic day 9.5 as
growth retardation, while the characteristic acd caudal truncationnt embryos. RNA in situ hybridization of wildtype and acd mutant littermate embryos
(C, D), the tailbud marker Fgf8 (E, F), and the T-box gene brachyury (G, H). Somite
mal in acd mutant embryos.
Table 2
Genotypes of (Acdacd/+×p53+/−) F2 progeny at weaning.
Acd genotypea p53 genotypeb
+/+ +/− −/−
+/+ 10 23 4
acd/+ 26 44 15
acd/acd 0 0 0
Χ2 50.5, df=8, pb0.0001 for predicted Mendelian ratios.
a acd denotes mutant allele.
b − denotes p53-null allele.
Table 3
Genotypes of (Acdacd/+×p53+/−) F2 progeny at E15.5–E16.5.
Acd genotypea P53 genotypeb
+/+ +/− −/−
+/+ 8 30 6
acd/+ 16 51 21
acd/acd 7 23 9
Χ2 11.8, df=8, 0.05bpb0.2 for predicted Mendelian ratios.
a acd denotes mutant allele.
b − denotes p53-null allele.
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growth retardation is accompanied by a dramatic increase in cellular
apoptosis but no signiﬁcant changes in proliferation. Our previous
observation of 0.3 chromosomal fusions per metaphase in acdmutant
MEF cells is consistent with the extent of apoptosis observed in tissue
sections (Else et al., 2007). The observed apoptosis was widespread
throughout the embryo rather than restricted to the caudal region,
which is consistent with the global growth retardation that we
observed at these timepoints. The most likely explanation for the
widespread apoptosis in acd mutant embryos is that telomere
dysfunction causes genomic instability leading to activation of p53
with subsequent apoptosis. Because development proceeds in a
rostral-to-caudal fashion, it is possible that the caudal region of the
embryo becomes disproportionately affected due to apoptosis of
precursor cells that ultimately form the caudal region.
Several mutant mouse models with caudal truncation have
previously been described (Greco et al., 1996; Herrmann et al., 1990;
Sakai et al., 2001; Takada et al., 1994). Some of these havemutations in
genes encoding components of developmental signaling pathways
that regulate somitogenesis, the process by which the axial skeleton is
formed by partitioning presomitic mesoderm to form somites. This
process is accomplished by oscillating expressionof components of the
Notch and Wnt signaling pathways, along with opposing gradients of
Fgf and retinoic acid signaling that determines the somite segmenta-
tion boundary (Aulehla and Herrmann, 2004; Dubrulle and Pourquie,
2004). Although acd mutant embryos exhibit caudal dysgenesis with
vertebral and limbmalformations, somitogenesis is not disrupted, and
the expression of representatives of these major signaling pathways is
intact. While we previously reported decreased expression of some
markers of tail bud development in acd mutant embryos at a later
timepoint (E11.5), it was unclear whether this was due to a reduction
in the number of cells or alterations in the signaling pathways
themselves (Keegan et al., 2005). The data presented here establish
that the major signaling pathways regulating somitogenesis and tail
bud formation are intact, and argue for loss of cells as the mechanism
leading to the observed vertebral and limb anomalies.
Telomere dysfunction is known to lead to apoptosis or cell cycle
arrest via activation of p53, leading to the hypothesis that p53
deﬁciency might rescue phenotypes resulting from telomere dys-
function. In late generation Terc null mice, p53 deﬁciency signiﬁcantly
attenuated cell cycle and reproductive organ defects but not the
reduced telomere length, and in mice homozygous for a null allele of
the telomere repeat binding factor 1 gene (Terf1), p53 deﬁciency
partially attenuated the early embryonic lethality (Chin et al., 1999;
Karlseder et al., 2003). In other mouse models with genomic
instability, p53 deﬁciency rescues embryonic lethality caused by
disruption of the DNA repair genes Xrcc4 and DNA ligase IV and the
p53-interacting proteins Mdm2 and Mdm4 (Frank et al., 2000; Gao
et al., 2000; Jones et al., 1995; Montes de Oca Luna et al., 1995; Parant
et al., 2001). Deﬁciency of p53 also rescues neural tube defects
observed in splotch mutant mice, which have loss of function of the
Pax3 transcription factor (Pani et al., 2002). In our cross between
acd heterozygous and p53 null mice, we observed a striking rescue of
the skeletal anomalies of acd mutant embryos as a result of p53deﬁciency. This suggests that the vertebral and limb anomalies in acd
mutants are secondary to p53-dependent apoptosis, and our observed
rescue of cellular apoptosis in E10.5 acd/acd, p53−/−mutant embryos
conﬁrms this as themost likely mechanism.While apoptosis is known
to be integral to normal limb development (Zuzarte-Luis and Hurle,
2005), the role of p53-dependent apoptosis has only been studied in
the setting of radiation-induced limb malformations (Boreham et al.,
2002;Wang et al., 2000). The surprising ﬁnding of polydactyly in acd/
acd, p53−/− embryos suggests the possibility that p53-dependent
apoptosis is important during normal limb bud development.
However, the absence of limb abnormalities in most p53 null embryos
carrying an Acd wildtype allele (26/27 embryos) indicates that
telomere dysfunction is required for the polydactyly phenotype. This
suggests an alternative explanation that telomere dysfunction in the
developing limbs may actually generate a hyperproliferative response
that is only apparent when cells are unable to undergo apoptosis.
Although the early embryonic lethality of null alleles of other shelterin
components precludes analysis, it would be of interest to determine
the effect of p53 deﬁciency on other mouse models with genomic
instability, particularly those with embryonic malformations, to
determine whether there is indeed a shared mechanism.
p53 deﬁciency did not rescue the embryonic lethality of the acd
mutation. Incomplete rescue by p53 deﬁciency was also observed in
embryos harboring a knockout allele of the DNA repair gene Xrcc2,
although there was a partial rescue of the embryonic phenotype
(Adam et al., 2007), similar to acd mutant embryos. The reason for
lack of complete rescue of the acd phenotype is unclear, but could be
due to the role of p53-independent pathways that also regulate
apoptosis during development or genetic modiﬁers of the acdmutant
phenotype. Potential candidates for p53-independent pathways
include the p53 related proteins p63 and p73 (Yang et al., 2002),
and other pathways known to be involved in apoptosis and
senescence in response to DNA damage, including p16Ink4a, p19Arf,
and ATM (Ju and Rudolph, 2008).
It is clear that p53 plays a role in regulating apoptosis during
development. While mice homozygous for a null allele of p53 can
develop normally and survive to adulthood, some p53 null embryos
develop exencephaly and die in utero (Sah et al., 1995). Several
studies have examined the effect of ionizing radiation, which
produces double-stranded DNA breaks, on malformations in p53-
deﬁcient mice (Armstrong et al., 1995; Baatout et al., 2002; Bekaert
et al., 2005). Malformations including gastroschisis, polydactyly, cleft
palate, and growth retardation are signiﬁcantly increased when
fetuses or male parents are exposed to ionizing radiation (Armstrong
et al., 1995; Baatout et al., 2002), and telomere shortening is
associated with these malformations (Bekaert et al., 2005). p53
mutations have not been associated with birth defects in humans, but
comprehensive studies have not been published.
While telomere dysfunction has been well studied with respect to
cancer phenotypes, the study of congenital malformations due to
telomere dysfunction has been lacking. Thus, our use of the acd
mutant mouse model to study birth defects caused by telomere
dysfunction is unique. Null alleles of the other components of the
shelterin complex, including Terf2, Terf1, Pot1a, and Tin2, exhibit
Fig. 5. p53 deﬁciency rescues skeletal phenotype of acdmutant embryos. Skeletal staining of hindlimbs from acd×p53 intercross embryos at E16.5 shows the absence of medial digit
and tibia in acd/acd, p53+/+ limb (A). Normal number of digits in acd/acd, p53+/− limb (B). Preaxial polydactyly is noted in acd/acd, p53−/− limb (C). Wildtype embryo limb
pictured in panel (D). Skeletal staining of vertebral columns from acd×p53 intercross embryos at E16.5 shows multiple vertebral fusions throughout the length of the spinal column
in acd/acd, p53+/+ embryo (E). Multiple vertebral fusions are also noted in acd/acd, p53+/− embryo (F), but fewer than acd/acd, p53+/+ embryo. Complete lack of vertebral
fusions in acd/acd, p53−/− embryo (G). Vertebral column of wildtype embryo shown in panel (H). Limbs were removed from embryos in (E) and (G) for photography. All
photographs were taken at the same magniﬁcation. (I) Quantiﬁcation of percent abnormal vertebrae in each embryo reveals dose-dependent reduction of abnormal vertebrae with
increasing p53 deﬁciency. ⁎Denotes lack of statistical signiﬁcance (p=0.66), ⁎⁎denotes pb0.05, ⁎⁎⁎denotes pb0.0001.
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phenotypes difﬁcult (Celli and de Lange, 2005; Chiang et al., 2004b;
Hockemeyer et al., 2006; Karlseder et al., 2003;Wu et al., 2006).While
Pot1b null mice and acd mutant mice on a mixed genetic background
exhibit some phenotypic similarities (He et al., 2009; Hockemeyer
et al., 2008), developmental abnormalities have not been reported in
Pot1b null mice. The contribution of telomere dysfunction to adultTable 4
(Acdacd/+×p53+/−) intercross embryo hindlimb phenotypes.
Genotypes (Acd, p53) No. of embryos No. of hindlimbs Biﬁd digit Poly
+/+, +/+ 8 16 – –
+/+, +/− 30 60 – –
+/+, −/− 6 12 – –
acd/+, +/+ 16 32 – –
acd/+, +/− 51 102 – –
acd/+, −/− 21 42 – –
acd/acd, +/+ 7 14 – –
acd/acd, +/− 23 46 3 (6.5%) –
acd/acd, −/− 9 18 4 (22.2%) 11 (
Total 171 342
Numerical values represent number and (percentage) of hindlimbs with each phenotype, –
a Only found in the presence of hypoplasia or absent digit.phenotypes has been extensively analyzed using telomerase deﬁcient
mice with deletion of the Terc or Tert genes, but the only
developmental phenotype reported is an increased incidence in
rostral neural tube defects in late generation mutant embryos
(Herrera et al., 1999). Telomere dysfunction in telomerase deﬁcient
mice is due to critical telomere shortening, which takes several
generations to manifest. In contrast, the telomere dysfunction in acddactyly Normal Hypoplastic digits Absent digits Absent tibiaa
16 (100%) – – –
60 (100%) – – –
12 (100%) – – –
32 (100%) – – –
102 (100%) – – –
42 (100%) – – –
7 (50%) 5 (35.7%) 2 (14.3%) 2 (14.3%)
37 (80.4%) 4 (8.7%) 2 (4.4%) 3 (6.5%)
61.1%) 3 (16.7%) – – –
indicates 0 embryos with phenotype.
Fig. 6. p53 deﬁciency rescues cellular apoptosis in acd mutant embryos. Immunoﬂuorescence for cleaved caspase-3 (Casp-3) shows rare apoptotic cells in E10.5 wildtype (acd/+,
p53+/+ embryo tissue sections (A–C). A signiﬁcant increase in Casp-3 staining is observed in acd/acd, p53+/+ embryos (D–F). Only occasional Casp-3 positive cells are observed in
acd/acd, p53−/− embryos (G–I), demonstrating rescue of apoptosis by p53 deﬁciency. Scale bars represent 100 μm.
427C.N. Vlangos et al. / Developmental Biology 334 (2009) 418–428mutant mice, which is thought to be due to telomere uncapping and
deprotection, is present in the ﬁrst generation and severity does not
increase in later generations.
The caudal truncation, vertebral segmentation anomalies, and limb
hypoplasia in acd mutant embryos resemble the human phenotypes
of Caudal Regression syndrome and VACTERL association. While the
genetic causes of CRS and VACTERL association may be heteroge-
neous, the mechanisms that lead to the constellation of birth defects
in CRS and VACTERL are likely to be similar. Although the link
between genomic instability, apoptosis, and cancer is well estab-
lished, our study of the acd mouse model reveals that disruption of
processes that protect the genome and regulate the disposal of
damaged cells during development could be an important contributor
to CRS, VACTERL, and potentially other birth defect syndromes. The
fact that a ubiquitous process such as maintenance of telomeres
results in a tissue speciﬁc phenotype may seem surprising on the
surface. There are, however, parallels with the well accepted
observation that loss of cell cycle regulation and defective genome
maintenance have tissue speciﬁc consequences for cancer suscepti-
bility. Further study of the developmental phenotypes in acd mutant
mice will provide mechanistic insight into birth defects that are
caused by genomic instability in humans.
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